According to report reaching OYOGist.com, Pfizer and BIONTECH have developed a vaccine for Covid-19 that has proved effective during the ongoing phase 3 trial. This statement came as corona virus cases continue to rise in the world.
According to experiments, protection in patients begins seven days after the second of the two doses and 28 days after the first.
The Pfizer Chairman and CEO is confident that they are close to making a breakthrough in providing a vaccine that will end the health crises in the world. He said that this was much desired because covid-19 infections has reached an alarming level in recent tines and the death rate has been astronomically high. The two companies hope to supply up to 50 million doses of vaccine globally in 2020 and up to1.3 billion doses in 2021.
The phase 3 clinical trial which is the final stage of the new vaccine, BNT162b2 began in late July and 43,538 participants have taken part in the clinical trial of the vaccine and 90% have taken the second dose.
Pfizer said it needs to gather two months of the safety data after administering the final dose as required by the US Food And Drug Administration to be fit for Emergency Use Authorization by third week of November.
